Literature DB >> 28447249

Guest Editorial: Understanding of MPN and MDS/MPN based on molecular pathogenesis and clinical aspects.

Hironori Harada1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28447249     DOI： 10.1007/s12185-017-2244-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  5 in total

1.  Clonal architecture of chronic myelomonocytic leukemias.

Authors:  Raphaël Itzykson; Olivier Kosmider; Aline Renneville; Margot Morabito; Claude Preudhomme; Céline Berthon; Lionel Adès; Pierre Fenaux; Uwe Platzbecker; Olivier Gagey; Philippe Rameau; Guillaume Meurice; Cédric Oréar; François Delhommeau; Olivier A Bernard; Michaela Fontenay; William Vainchenker; Nathalie Droin; Eric Solary
Journal:  Blood       Date:  2013-01-14       Impact factor: 22.113

2.  Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms.

Authors:  Marito Araki; Yinjie Yang; Nami Masubuchi; Yumi Hironaka; Hiraku Takei; Soji Morishita; Yoshihisa Mizukami; Shin Kan; Shuichi Shirane; Yoko Edahiro; Yoshitaka Sunami; Akimichi Ohsaka; Norio Komatsu
Journal:  Blood       Date:  2016-01-27       Impact factor: 22.113

3.  Somatic SETBP1 mutations in myeloid malignancies.

Authors:  Hideki Makishima; Kenichi Yoshida; Nhu Nguyen; Bartlomiej Przychodzen; Masashi Sanada; Yusuke Okuno; Kwok Peng Ng; Kristbjorn O Gudmundsson; Bandana A Vishwakarma; Andres Jerez; Ines Gomez-Segui; Mariko Takahashi; Yuichi Shiraishi; Yasunobu Nagata; Kathryn Guinta; Hiraku Mori; Mikkael A Sekeres; Kenichi Chiba; Hiroko Tanaka; Hideki Muramatsu; Hirotoshi Sakaguchi; Ronald L Paquette; Michael A McDevitt; Seiji Kojima; Yogen Saunthararajah; Satoru Miyano; Lee-Yung Shih; Yang Du; Seishi Ogawa; Jaroslaw P Maciejewski
Journal:  Nat Genet       Date:  2013-07-07       Impact factor: 38.330

Review 4.  Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapies.

Authors:  Hironori Harada; Yuka Harada
Journal:  Cancer Sci       Date:  2015-02-25       Impact factor: 6.716

5.  Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.

Authors:  Stanley Chun-Wei Lee; Heidi Dvinge; Eunhee Kim; Hana Cho; Jean-Baptiste Micol; Young Rock Chung; Benjamin H Durham; Akihide Yoshimi; Young Joon Kim; Michael Thomas; Camille Lobry; Chun-Wei Chen; Alessandro Pastore; Justin Taylor; Xujun Wang; Andrei Krivtsov; Scott A Armstrong; James Palacino; Silvia Buonamici; Peter G Smith; Robert K Bradley; Omar Abdel-Wahab
Journal:  Nat Med       Date:  2016-05-02       Impact factor: 53.440
  5 in total
  1 in total

1.  [Clinical and laboratory characteristics of juvenile myelomonocytic leukemia].

Authors:  Yuan-Yuan Wu; Sheng-Yang Cai; Wei Huang; Si-Si Li; Wei Li; Ao Dong
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.